Spironolactone to increase natriuresis in congestive heart failure with cardiorenal syndrome.
Acta cardiologica（2019）
摘要
Spironolactone use upfront in AHF patients at high risk for cardiorenal syndrome is safe and increases natriuresis.
更多查看译文
关键词
Diuretics,hyperkalaemia,hypokalaemia,natriuresis,spironolactone,systolic heart failure
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要